ニュース

Applied Clinical Trials Online9 時間
Roche’s Susvimo Lands FDA Approval for Diabetic Retinopathy Based on Phase III Pavilion ...
One-year results from the Pavilion study showed patients who received Susvimo (ranibizumab) refilled every nine months ...
Applied Clinical Trials Online11 時間
The Role of AI in Solving Clinical Trial Diversity and Access Challenges
In this video interview, Michel van Harten, MD, CEO, myTomorrows, highlights how artificial intelligence can be used to address logistical barriers such as access and treatment cost.
Applied Clinical Trials Online14 時間
Nerandomilast Meets Primary Endpoints in Phase III IPF and PPF Trials, Shows Significant ...
Data from the FIBRONEER-IPF and FIBRONEER-ILD studies, published in The New England Journal of Medicine, highlight ...
appliedclinicaltrialsonline1 日
Susan Vallow
Applied Clinical Trials is the thought leader in pharmaceutical drug development operations and clinical trial design, management, and monitoring.
appliedclinicaltrialsonline1 日
Kirsten Sherman Cervati
Upping the Migraine Intelligence Quotient: RWD sheds light on prevalence rates, providers and treatment variation ...
Applied Clinical Trials Online1 日
FDA Outlines Updated Requirement for Placebo-Controlled Trials in Vaccine Research
In an article recently published by The New England Journal of Medicine, FDA higher-ups Vinay Prasad, MD, MPH; and Martin A.
Applied Clinical Trials Online1 日
FDA Panel Votes Against Columvi-GemOx sBLA for R/R DLBCL Over Regional Data Concerns from ...
The FDA’s Oncologic Drugs Advisory Committee voted against an application for Columvi (glofitamab) plus GemOx for ...
Applied Clinical Trials Online1 日
Bridging Innovation and Trust with Artificial Intelligence
In this video interview, Michel van Harten, MD, CEO, myTomorrows, discusses where the clinical research industry currently stands with AI adoption.
appliedclinicaltrialsonline2 日
JoAnne Bronikowski, BSCS, RAC
Upping the Migraine Intelligence Quotient: RWD sheds light on prevalence rates, providers and treatment variation ...
appliedclinicaltrialsonline2 日
Aliz Mathild Vega Rodriguez
Upping the Migraine Intelligence Quotient: RWD sheds light on prevalence rates, providers and treatment variation ...
appliedclinicaltrialsonline2 日
Monique Adams, PhD
Upping the Migraine Intelligence Quotient: RWD sheds light on prevalence rates, providers and treatment variation ...
appliedclinicaltrialsonline2 日
Mac Winslow
Upping the Migraine Intelligence Quotient: RWD sheds light on prevalence rates, providers and treatment variation ...